Votrient Adverse Event Report 2018

$19.99

This report includes data from the FDA’s Adverse Events Reports for 2018.  We removed reports where the subject of the report was taking only this drug. This report provides the following fields:

  • ID
  • Patient Summary
  • Patient Gender
  • Patient Age
  • Drug Products
  • Drug Reactions

Description

Votrient (pazopanib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Votrient is used to treat advanced renal cell carcinoma (kidney cancer). Votrient is also used to treat soft tissue sarcoma (a tumor that can develop in or around muscles, tendons, joints, organs, or blood vessels). Votrient is usually given after other cancer medications have been tried without successful treatment of soft tissue sarcoma.https://www.drugs.com/votrient.html

Contact US

484-352-2642

What is an Adverse Event Report?

The FDA Adverse Event Reporting System (FAERS) is a database that contains adverse event reports, medication error reports and product quality complaints resulting in adverse events that were submitted to FDA.